D6 Hormones and endocrine axes

Topic

An automated complete blood count (CBC) simultaneously analyzes three blood cell lines: red blood cells (and their indices), white blood cells (including their differential count), and platelets. Together with coagulation tests, blood smears, and reticulocyte counts, it enables the investigation of the causes of anemia and various hemostatic disorders.

One of the key erythrocyte indices is the average size of red blood cells, which is used to classify anemias. A low value indicates microcytic anemia, commonly caused by iron deficiency or thalassemia. A normal value indicates normocytic anemia, which may be associated with hemolysis or chronic kidney disease. An elevated value indicates macrocytic anemia, which can result from vitamin B12 or folate deficiency, hypothyroidism, liver disease, or certain medications. Another index measures the average hemoglobin concentration within the erythrocyte. A true elevation above 36 g/dL is rare and is particularly associated with a hereditary condition characterized by spherical erythrocytes.

Coagulation is assessed using two complementary global tests. Prothrombin time evaluates one of the activation pathways and the final common pathway; it may be prolonged in cases of liver disease, vitamin K deficiency, or treatment with certain anticoagulants. Activated partial thromboplastin time evaluates a different pathway as well as the common pathway; it is altered in hemophilia, heparin therapy, or the presence of lupus anticoagulant. When both tests are prolonged, there may be a defect in factors belonging to the common pathway or widespread factor consumption, as seen in disseminated intravascular coagulation.

The peripheral blood smear complements automated analysis through direct microscopic observation of the cells. It allows for the identification of red blood cells fragmented by mechanical damage, spherical erythrocytes associated with certain types of hemolysis, target cells linked to hemoglobin abnormalities or liver disease, immature cells characteristic of acute leukemias, and even microorganisms within erythrocytes, as seen in malaria. Given the wealth of morphological information it provides through a relatively simple procedure, it serves as a highly useful diagnostic tool.

Assessing platelet function requires additional tests, as platelet count alone does not necessarily indicate proper function. A specialized device passes blood through a small aperture coated with platelet-activating substances and measures the time required for it to close. A prolonged closure time indicates impaired platelet function and allows for the detection of both hereditary defects and the effects of antiplatelet medications, such as aspirin and clopidogrel. This technique has largely replaced the traditional bleeding time test.

Reticulocytes are red blood cells recently released from the bone marrow, directly reflecting its production activity. Their percentage must be interpreted in the context of the degree of anemia; therefore, it is adjusted using the patient's hematocrit relative to a normal value of approximately 45%. According to the text, a corrected index of less than 2 indicates an inadequate bone marrow response, which can occur in cases of aplasia, chronic kidney disease, or nutritional deficiencies. A value greater than 3 indicates an active compensatory response to erythrocyte destruction or loss, such as in hemolysis or hemorrhage. The proportion of particularly immature reticulocytes also provides information on the speed of the bone marrow's response.

Taken together, these tools allow for the reconstruction of various hematological aspects from a blood sample. Erythrocyte indices provide clues regarding the origin of anemia; coagulation tests help pinpoint abnormalities in the various pathways; The blood smear provides morphological information that the automated analyzer does not detect; specific tests evaluate platelet function, and reticulocyte counts indicate whether the bone marrow is responding adequately. Interpreting these results together makes it possible to determine whether anemia stems from insufficient production, destruction, or loss of red blood cells, while simultaneously assessing hemostatic function.

ID:2280